Identification of a blood-borne miRNA signature of synovial sarcoma
Conclusion:
Our results have identified a specific whole blood miRNA signature that may serve as an independent biomarker for the diagnosis of local recurrence or distant metastasis of synovial sarcoma. It even distinguishes synovial sarcoma from other sarcoma subtypes, thus potentially serving as a specific biomarker for synovial sarcoma.
Source: Molecular Cancer - Category: Cancer & Oncology Authors: Alba FrickePrisca UllrichJürgen HeinzDietmar PfeiferJutta ScholberGeorg HergetOliver HauschildPeter BronsertG. StarkHolger BannaschSteffen EisenhardtDavid Braig Source Type: research
More News: Bone Cancers | Cancer | Cancer & Oncology | Cancer in Adolescents | Cancer in Young Adults | Ewing's Sarcoma | Genetics | Leiomyosarcoma | Liposarcoma | Sarcomas | Synovial Sarcoma | Translocation